Clinical Trial Update: Tdap and Biomarkers of Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 trial update for a Tdap-based approach investigating biomarkers in late-onset Alzheimer’s disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Late-onset Alzheimer Disease

Snippet

Sponsor: Mindful Diagnostics and Therapeutics, LLC | Conditions: Alzheimer Disease, Late Onset | Phase 1, Phase 2 | Status: UNKNOWN